Based on the results of these trials, we considered the following dosages to define a treatment as being in the "therapeutic range", so following the CANMAT recommendations: lithium blood levels ≥0.5 mEq/L; valproate ≥ 750 mg daily; carbamazepine ≥600 mg daily; lamotrigine ≥ 50 mg daily; olanzapine ≥ 5 mg daily; risperidone ≥ 2 mg daily; quetiapine ≥150 mg daily.
Finally, we used the following means to define the benign or malignant nature of the lesions: 57 lesions (32.2%) were followed up after 6 months and/or additionally examined by other imaging methods and finally staged down to BI-RADS® 2 and consequently categorized as certainly benign.
We need to establish the following result to define the solutions for the given problem.
The study was developed in 3 phases, with the following aims: To define the most appropriate management process for atrial fibrillation (AF) from the point of view of the health professionals and the patients.
We use the following question to define formal employment or formality: "do you have access to medical aid in...?" If the household head answers either Mexican Institute of Social Security or Institute of Services and Social Security for the State Workers, we consider him or her to be formally employed.
In order to evaluate the accuracy of beat-tracking methods, we use the following thresholds to define successful beat detection and tempo estimations from ground truth: 150 msec for detected beats and 10 bpm for estimated tempos, respectively.
For the purpose of this study, we applied the following criteria to define infection: (1) presence of clinical signs of infection (pneumonia, urinary tract infections, fever of unknown origin); (2) serum concentrations of C- reactive protein >50 mg/mL; and (3) procalcitonin serum concentrations >0.5 ng/mL.
We used the following criteria to define presence of PAD: 1) an ankle brachial index (ABI) ≤0.9 at rest or 1 min after exercise; or 2) presence of poorly compressible arteries; or 3) normal ABI but prior history of revascularization for PAD [22].
When quantifying cells in specific folia, we used the following criteria to define the areas to quantify.
We use the following heuristics to define the positive training instances: we initialize a threshold t to be the number of the variant callers (or a number defined by the user at program start).
